Quantum BioPharma Calls Shareholders to Participate in Market Manipulation Lawsuit
Quantum BioPharma is taking a strong stance against market manipulation, filing a complaint in the United States courts against CIBC World Markets, RBC Dominion Securities, and others. The company and its shareholders have experienced financial and emotional losses due to this alleged manipulation. To address these issues, Quantum BioPharma has assembled legal teams to seek recovery of all losses and damages.
These legal teams are working on a contingency basis, meaning that the company will not be billed for legal costs. Quantum BioPharma is seeking damages of over $700 million that it believes it has suffered. Shareholders can stay updated on the case through the Quantum vs Banks page on the company’s website, which will be periodically updated.
Formerly known as FSD Pharma and trading under the symbol HUGE, Quantum BioPharma is calling on shareholders to join in seeking justice for the company and affected shareholders. The more shareholders come forward to share details of their losses, the stronger the case becomes against the alleged perpetrators of financial harm.
In addition to these legal actions, Quantum BioPharma continues to make strides in its financial growth and stability. Stay tuned for the upcoming earnings report and other developments within the company.
